Medidata Rave Imaging Reaches Milestone, Supporting More Than 1,000 Clinical Studies

A Rapidly Growing Trend, More than 50% of Clinical Trials Now Involve Medical Imaging

Medidata, a Dassault Systèmes company, today announced that Rave Imaging, the company’s cloud-based, secure clinical trial imaging management platform, has reached a significant milestone, having supported more than 1,000 imaging studies.

Rave Imaging, built on the Medidata Unified Platform, processes more than 100 million images annually. The technology provides unprecedented real-time visibility into all imaging-related trial activities across all Rave Imaging trials to enhance study efficiency.

With more than 50% of clinical trials involving medical imaging, sponsors require a trusted, secure, and integrated technology to manage the increasing amount and complexity of imaging data.*

“Medidata continues to be an outstanding partner for ICON Medical Imaging. Our close relationship over the years has resulted not only in reduced timelines and increased value with our sponsors but also improved ease of use and decreased administrative burden for sites,” said Paul J. McCracken, Ph.D., vice president, head of medical imaging (IMI), ICON Clinical Research. “We’ve leveraged Rave Imaging on many studies because of our confidence in the technology’s reliability, flexibility, and continued innovation (such as in machine learning) to help us successfully deliver all types of current and anticipated imaging trial needs.”

Rave Imaging’s structured approach to image submission reduces the time and cost associated with image management, while increasing data quality and confidence. The technology provides:

  • Unified site experience with a single solution for all sites across all Rave Imaging trials and Core Labs
  • Flexibility to select and integrate with any Core Labs, system, or vendor
  • Standardized image submission processes including acquisition, de-identification, edit checks, distribution, review, and archiving across all trials and Core Labs
  • Data security adherent to privacy and information management guidelines

“Medidata’s Rave Imaging system has powered many of our key studies over the past eight years.  Medidata continues to innovate and invest in their imaging technology, giving us the robust functionality we need to run efficient trials with the quality we trust,” said Blessie Concepcion, director, Global Clinical Trials at Boston Scientific. “Medical Imaging is a critical component of many of our trials. It’s essential to have a technology partner like Medidata that will bring the expertise, experience, and service to help us get our devices to market faster.”

Integration with the other components of Medidata Unified Platform uniquely positions Rave Imaging to serve as an essential tool that can be used to collect imaging outcomes and then automatically correlate them with clinical outcomes. In addition, Medidata continues to invest in Rave Imaging, with a particular focus on artificial intelligence algorithms — such as automatic lesion detection and automatic anatomical verification — that can increase the efficiency of trials, while addressing cost and efficiency challenges, and improving data quality.

“This is a wonderful milestone to celebrate with our outstanding team and pioneering clients,” said Dr. Rama Kondru, co-CEO, Medidata. “With the flurry of M&A activity in the imaging technology and core lab space, it will be critical for sponsors to optimize their medical image management strategy with a trusted, experienced, enterprise partner. Medidata is ideally suited to be the partner of choice, with studies across 21,000 sites connected with over 75 Core Labs and contract research organizations (CROs).”

Medidata is a wholly-owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

SourceMedidata
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Building on its ZEISS Medical Ecosystem, several of the new innovations enable seamless data integration and management across the cataract and refractive workflows, creating a new standard for efficient, personalized ophthalmic care.
MinXray MinXray, a leading manufacturer of imaging systems for medical and veterinary use, recently sent its Impact Wireless X-ray system with a group of researchers...
New supply contract to bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to the Central region branch of the Portuguese League Against Cancer
KA Imaging reported a collection of positive metrics to its stakeholders, with revenue four times larger than that of the previous year and a 38% growth in headcount in 2023. The positive trend continues to be observed in Q1 2024.
Isaac Zaworski, President of Sectra advises: "Collaborating across sites and providing efficient radiology workflows are needed to cope with the increasing imaging volumes. This new customer is the 60th healthcare provider to use Sectra in the US Midwest and I'm pleased to be continuing our work in this area. With our local experience as well as our knowledge in providing multi-site solutions for large organizations we will help them on this journey in the best way possible."

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version